title: Giant vascular malformation with thrombocytopenia in a newborn.
authors.affiliation: 1University of Queensland School of Medicine, Brisbane, Queensland, Australia.
authors.forename: Asia
authors.initials: A
authors.lastname: Downing
authors.forename: Aman
authors.initials: A
authors.lastname: Chauhan
authors.forename: Craig
authors.initials: C
authors.lastname: Lotterman
authors.forename: Randall
authors.initials: R
authors.lastname: Craver
authors.forename: Raj
authors.initials: R
authors.lastname: Warrier
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D001132:Arm / Q000098:blood supply / Q000473:pathology; D005260:Female; D006390:Hemangioendothelioma / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D006984:Hypertrophy; D007231:Infant, Newborn; D059885:Kasabach-Merritt Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D008279:Magnetic Resonance Imaging; D008776:Methylprednisolone Hemisuccinate / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D012514:Sarcoma, Kaposi / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D054079:Vascular Malformations / Q000209:etiology*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000893:Anti-Inflammatory Agents; D000972:Antineoplastic Agents, Phytogenic; D008776:Methylprednisolone Hemisuccinate; D014750:Vincristine; D011239:Prednisolone